SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039357
Filing Date
2020-08-11
Accepted
2020-08-11 17:13:50
Documents
56
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q umrx-10q_20200630.htm 10-Q 1519108
2 EX-31.1 umrx-ex311_33.htm EX-31.1 10006
3 EX-31.2 umrx-ex312_32.htm EX-31.2 9952
4 EX-32.1 umrx-ex321_31.htm EX-32.1 5984
5 EX-32.2 umrx-ex322_30.htm EX-32.2 5922
  Complete submission text file 0001564590-20-039357.txt   4499193

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT umrx-20200630.xml EX-101.INS 670518
7 XBRL TAXONOMY EXTENSION SCHEMA umrx-20200630.xsd EX-101.SCH 40243
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE umrx-20200630_cal.xml EX-101.CAL 31401
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE umrx-20200630_def.xml EX-101.DEF 130275
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE umrx-20200630_lab.xml EX-101.LAB 316134
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE umrx-20200630_pre.xml EX-101.PRE 236290
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 201093334
SIC: 2834 Pharmaceutical Preparations